Literature DB >> 19413797

Reduced affective symptoms during tobacco dependence treatment with varenicline.

Martin Grosshans1, Jochen Mutschler, Derik Hermann, Karl Mann, Alexander Diehl.   

Abstract

BACKGROUND: The nicotinic acetylcholine receptor partial agonist varenicline has been shown to be effective in the treatment of tobacco dependence, but has been reported to induce exacerbations of psychiatric symptoms in subjects with pre-existing psychiatric disorders. CASE DESCRIPTION: We report a tobacco-dependent patient who developed depression and suicidal tendencies during several cessation attempts, but was finally able to stay nicotine-abstinent by taking varenicline.
CONCLUSION: In this case varenicline did not lead to exacerbation but appeared to improve the affective symptoms.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19413797     DOI: 10.1111/j.1360-0443.2009.02537.x

Source DB:  PubMed          Journal:  Addiction        ISSN: 0965-2140            Impact factor:   6.526


  5 in total

Review 1.  [Treatment of tobacco dependence: a responsibility of psychiatry and addiction medicine].

Authors:  A Batra; H M Friederich; U Lutz
Journal:  Nervenarzt       Date:  2009-09       Impact factor: 1.214

Review 2.  Neuronal nicotinic acetylcholine receptors as pharmacotherapeutic targets for the treatment of alcohol use disorders.

Authors:  S Chatterjee; S E Bartlett
Journal:  CNS Neurol Disord Drug Targets       Date:  2010-03       Impact factor: 4.388

3.  Smoking cessation after brain damage does not lead to increased depression: implications for understanding the psychiatric complications of varenicline.

Authors:  Daniel Tranel; Ashton McNutt; Antoine Bechara
Journal:  Cogn Behav Neurol       Date:  2012-03       Impact factor: 1.600

4.  Varenicline for Smoking Cessation in Schizophrenia: Safety and Effectiveness in a 12-Week, Open-Label Trial.

Authors:  Gladys N Pachas; Corinne Cather; Sarah A Pratt; Bettina Hoeppner; Johanna Nino; Sara V Carlini; Eric D Achtyes; Harry Lando; Kim T Mueser; Nancy A Rigotti; Donald C Goff; A Eden Evins
Journal:  J Dual Diagn       Date:  2012-05-11

5.  Efficacy and Safety of Varenicline for Smoking Cessation in Schizophrenia: A Meta-Analysis.

Authors:  Saeed Ahmed; Sanya Virani; Vijaya P Kotapati; Ramya Bachu; Mahwish Adnan; Ali M Khan; Aarij Zubair; Gulshan Begum; Jeevan Kumar; Mustafa Qureshi; Rizwan Ahmed
Journal:  Front Psychiatry       Date:  2018-09-19       Impact factor: 4.157

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.